Overview

Oral Mucosal Absorption Study of Bicalutamide New Formulation

Status:
Terminated
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the presence or absence of oral mucosal absorption of bicalutamide after ICI176,334.1 is given to Japanese healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Bicalutamide